The Human Gut Bacterial Genotoxin Colibactin Alkylates DNA

Wilson, Matthew R., Jiang, Yindi, Villalta, Peter W., Stornetta, Alessia, Boudreau, Paul D., Carrá, Andrea, Brennan, Caitlin A., Chun, Eunyoung +6 more·2019·Science
DOI 10.1126/science.aar7785

Cited by (635)

Items 301–400 of 635

  1. Progress on targeted discovery of microbial natural products based on the predictions of both structure and activity
    Yuwei Zhang, Jian-Fa Zong, Yufeng Liu, Keyu Zhou, Haibo Shi, Wen‐Bing Yin, Ling Liu, Yihua Chen · 2025 · Natural Product Reports
  2. Mechanistic dissection unmasks colibactin as a prevalent mutagenic driver of cancer
    Hilmar Berger, Thomas F. Meyer · 2021 · Cancer Cell
  3. Tackling the Threat of Cancer Due to Pathobionts Producing Colibactin: Is Mesalamine the Magic Bullet?
    Min Tang-Fichaux, Priscilla Branchu, Jean‐Philippe Nougayrède, Éric Oswald · 2021 · Toxins
  4. Biosynthesis of Gut‐Microbiota‐Derived Lantibiotics Reveals a Subgroup of S8 Family Proteases for Class III Leader Removal
    Yingying Zhang, Zhilai Hong, Liang Zhou, Zhenkun Zhang, Ting Tang, Erpeng Guo, Jie Zheng, Ciji Wang, Lei Dai, Tong Si et al. · 2021 · Angewandte Chemie International Edition
  5. Human Microbiota in Esophageal Adenocarcinoma: Pathogenesis, Diagnosis, Prognosis and Therapeutic Implications
    Wanyue Dan, Lihua Peng, Bin Yan, Zhengpeng Li, Fei Pan · 2022 · Frontiers in Microbiology
  6. Regulation of innate immune system function by the microbiome: Consequences for tumor immunity and cancer immunotherapy
    Irene Mattiola, Andreas Diefenbach · 2023 · Seminars in Immunology
  7. Discovery of Lactomodulin, a Unique Microbiome-Derived Peptide That Exhibits Dual Anti-Inflammatory and Antimicrobial Activity against Multidrug-Resistant Pathogens
    Walaa Kamel Mousa, Rose Ghemrawi, Tareq Abu‐Izneid, Azza Ramadan, Farah Ibrahim Al-Marzooq · 2023 · International Journal of Molecular Sciences
  8. Variety of Fruit and Vegetables and Alcohol Intake are Associated with Gut Microbial Species and Gene Abundance in Colorectal Cancer Survivors
    Than S. Kyaw, Vaibhav Upadhyay, Irina V. Tolstykh, Katherine Van Loon, Angela Laffan, Dalila Stanfield, Daryll Gempis, Stacey A. Kenfield, June M. Chan, Sorbarikor Piawah et al. · 2023 · American Journal of Clinical Nutrition
  9. Escherichia coli on colorectal cancer: A two‐edged sword
    Jian Chu, Yinhang Wu, Zhuang Jing, Qu Zhanbo, Wang Zefeng, Shuwen Han · 2024 · Microbial Biotechnology
  10. Network modeling of patients' biomolecular profiles for clinical phenotype/outcome prediction
    Jessica Gliozzo, Paolo Perlasca, Marco Mesiti, Elena Casiraghi, Viviana Vallacchi, Elisabetta Vergani, Marco Frasca, Giuliano Grossi, Alessandro Petrini, Matteo Ré et al. · 2020 · Scientific Reports
  11. Can FMT Cause or Prevent CRC? Maybe, But There Is More to Consider
    Alexander Khoruts · 2021 · Gastroenterology
  12. Microbiota utilization of intestinal amino acids modulates cancer progression and anticancer immunity
    Shanshan Qiao, Ting-Ting Li, Mingeum Jeong, Chuanfa LIU, Sayaka Mizutani, Sung-Min Hwang, Yaxin Li, Mengze Lyu, Kazuhiro Nishiyama, Yu-Ang Tang et al. · 2026 · Cell Host & Microbe
  13. Engineering bacteriophages for gut health: precision antimicrobials and beyond
    Mengmeng Xu, Shuling Chen, Hai-Long Pei, Lin Hu, Yong-Sheng Zhang · 2026 · Journal of Nanobiotechnology
  14. From Tumor Cells to Endothelium and Gut Microbiome: A Complex Interaction Favoring the Metastasis Cascade
    Ali Hussein Abdel Sater, Youssef Bouferraa, Ghid Amhaz, Yolla Haibe, Ahmed El Lakkiss, Ali I. Shamseddine · 2022 · Frontiers in Oncology
  15. Liquid Chromatography–Mass Spectrometry Screening of Cyclophosphamide DNA Damage In Vitro and in Patients Undergoing Chemotherapy Treatment
    Valeria Guidolin, Foster C. Jacobs, Margaret L. MacMillan, Peter W. Villalta, Silvia Balbo · 2023 · Chemical Research in Toxicology
  16. Engineered bacterial therapeutics for detecting and treating CRC
    Nicole Siguenza, Arianna Brevi, Joanna T. Zhang, Arman Pabani, Abhinav Bhushan, Moumita Das, Yousong Ding, Jeff Hasty, Pradipta Ghosh, Amir Zarrinpar · 2024 · Trends in cancer
  17. Targeting bacterial metabolites in tumor for cancer therapy: An alternative approach for targeting tumor-associated bacteria
    Guofeng Ji, Jingjing Zhao, Xinghui Si, Wantong Song · 2024 · Advanced Drug Delivery Reviews
  18. Individuality and generality of intratumoral microbiome in the three most prevalent gynecological malignancies: an observational study
    Qin Xiao, Wen‐jie Chen, Fei Ling Wu, Xinyi Zhang, Xia Li, Jing Wei, Tingtao Chen, Zhaoxia Liu · 2024 · Microbiology Spectrum
  19. Signaling Natural Products from Human Pathogenic Bacteria
    Zhijuan Hu, Wenjun Zhang · 2019 · ACS Infectious Diseases
  20. Intestinal colonization of genotoxic Escherichia coli strains encoding colibactin and cytotoxic necrotizing factor in small mammal pets
    Niora J. Fabian, Anthony J. Mannion, Yan Feng, Carolyn M. Madden, James G. Fox · 2019 · Veterinary Microbiology
  21. Applications of Adductomics in Chemically Induced Adverse Outcomes and Major Emphasis on DNA Adductomics: A Pathbreaking Tool in Biomedical Research
    Tapan Behl, Mahesh Rachamalla, Agnieszka Najda, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Saurabh Bhatia, Ahmed Al‐Harrasi, Sridevi Chigurupati, Celia Bertha Vargas-De-La-Cruz et al. · 2021 · International Journal of Molecular Sciences
  22. FLEXiGUT: Rationale for exposomics associations with chronic low-grade gut inflammation
    Roger Peró-Gascón, Lieselot Hemeryck, Giulia Poma, Gwen Falony, Tim S. Nawrot, Jeroen Raes, Lynn Vanhaecke, Marthe De Boevre, Adrian Covaci, Sarah De Saeger · 2021 · Environment International
  23. Western lifestyle as a driver of dysbiosis in colorectal cancer
    Nora J. Foegeding, Zachary Jones, Mariana Xavier Byndloss · 2021 · Disease Models & Mechanisms
  24. Pharmacomicrobiomics in precision cancer therapy: bench to bedside
    Khanh Le Ngoc, Tran Thu Ha Pham, Tiep Khac Nguyen, Phung Thanh Huong · 2024 · Frontiers in Immunology
  25. Microbiota, chronic inflammation, and health: The promise of inflammatome and inflammatomics for precision medicine and health care
    Huan Zhang, Bing Jun Yang Lee, Tong Wang, Xuesong Xiang, Yafang Tan, Yanping Han, Yujing Bi, Fachao Zhi, Xin Wang, Fang He et al. · 2025 · hLife
  26. Health-promoting functions and related comprehensive molecular mechanisms of tea: from the perspectives of anti-inflammatory, lipid-lowering, glucose-lowering and anti-cancer effects
    Jingguo Xu, Shiyao Jia, Yuting Ren, Yao Zhang, Junyan Zhang, Chao Tang, Juan Kan, Jun Liu, Yao Wang · 2025 · Food Bioscience
  27. Gut microbiome in gastrointestinal neoplasms: from mechanisms to precision therapeutic strategies
    Jiaqian Song, Weidong Zhang, Deqiang Wang · 2025 · Gut Pathogens
  28. The multi-kingdom cancer microbiome
    Anders B. Dohlman, Xiangyu Pan, Laurence Zitvogel, Iliyan Dimitrov Iliev · 2025 · Nature Microbiology
  29. Surgical Treatment for Colorectal Cancer Partially Restores Gut Microbiome and Metabolome Traits
    Hirotsugu Shiroma, Satoshi Shiba, Pande Putu Erawijantari, Hiroyuki Takamaru, Masayoshi Yamada, Taku Sakamoto, Yukihide Kanemitsu, Sayaka Mizutani, Tomoyoshi Soga, Yutaka Saito et al. · 2022 · mSystems
  30. Cancer evolution: Special focus on the immune aspect of cancer
    Xiao Hu, Zhengxi Chen, Zheng Wang, Qian Xiao · 2022 · Seminars in Cancer Biology
  31. The Escherichia coli colibactin resistance protein ClbS is a novel DNA binding protein that protects DNA from nucleolytic degradation
    Katja Molan, Zdravko Podlesek, Vesna Hodnik, Matej Butala, Éric Oswald, Darja Žgur Bertok · 2019 · DNA repair
  32. Identification of an N′-Nitrosonornicotine-Specific Deoxyadenosine Adduct in Rat Liver and Lung DNA
    Yupeng Li, Stephen S. Hecht · 2021 · Chemical Research in Toxicology
  33. Gut Microbiota in Colorectal Cancer: Associations, Mechanisms, and Clinical Approaches
    Cayetano Pleguezuelos‐Manzano, Jens Puschhof, Hans C. Clevers · 2021 · Annual Review of Cancer Biology
  34. StrainPanDA: Linked reconstruction of strain composition and gene content profiles via pangenome‐based decomposition of metagenomic data
    Han Hu, Yuxiang Tan, Chenhao Li, Junyu Chen, Yan Kou, Zhenjiang Zech Xu, Yang‐Yu Liu, Yan Qin Tan, Lei Dai · 2022 · iMeta
  35. Microbial influence on triggering and treatment of host cancer: An intestinal barrier perspective
    Henan Zhang, Junrui Wu, Na Li, Rina Wu, Wei Chen · 2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  36. Purification, characterization and cytotoxic activities of individual tRNAs from Escherichia coli
    Kai‐Yue Cao, Yu Pan, Tong‐Meng Yan, Zhi‐Hong Jiang · 2019 · International Journal of Biological Macromolecules
  37. Potential role of intratumor bacteria outside the gastrointestinal tract: More than passengers
    Zhu Liu, Lian‐Lian Hong, Zhi‐Qiang Ling · 2023 · Cancer Medicine
  38. Mass spectrometry-based metabolomics approaches to interrogate host–microbiome interactions in mammalian systems
    Atharva S. Kulkarni, Guilherme Carrara Moreira Paiva, Jiangpeiyun Jin, Jarrod A. Laro, Thilini Peramuna, Laura‐Isobel McCall, Neha Garg · 2025 · Natural Product Reports
  39. The Interplay Between the Gut Microbiota and Colorectal Cancer: A Review of the Literature
    Marco Cintoni, Marta Palombaro, E. Zoli, Giuseppe D’Agostino, Gabriele Pulcini, Elena Leonardi, Pauline Celine Raoul, Emanuele Rinninella, Flavio De Maio, Esmeralda Capristo et al. · 2025 · Microorganisms
  40. Determination of biomarkers associated with neoadjuvant treatment response focusing on colibactin-producing Escherichia coli in patients with mid or low rectal cancer: a prospective clinical study protocol (MICARE)
    Christophe Taoum, Guillaume Carrier, Marta Jarlier, Gwenaëlle Roche, Johan Gagnière, Catherine Fiess, Hélène de Forges, Caroline Chevarin, Pierre‐Emmanuel Colombo, Nicolas Barnich et al. · 2022 · BMJ Open
  41. Bacteria and macrophages in the tumor microenvironment
    Shiyao Sherrie Xu, Yan Xiong, Beibei Fu, Dong Li Guo, Zhou Sha, Xiaoyuan Lin, Haibo Wu · 2023 · Frontiers in Microbiology
  42. The colorectal cancer-specific microbiome regulation and immune response activation via an artificial biomimetic nanovaccine
    Xiaoduan Zhuang, Bang Li, Xiaoyan Liu, Tingting Fan, Xinyue Lan, Xinying Wang, Meng Yu · 2023 · Chemical Engineering Journal
  43. Organoids in gastrointestinal diseases: from bench to clinic
    Qinying Wang, Fanying Guo, Qinyuan Zhang, TingTing Hu, YuTao Jin, Yongzhi Yang, Yanlei Ma · 2024 · MedComm
  44. Dysfunctional mucus structure in cystic fibrosis increases vulnerability to colibactin-mediated DNA adducts in the colon mucosa
    Amanda Mandarino Alves, Chiara Lecchi, Sharon Lopez, Alessia Stornetta, Prince P. Mathai, Peter W. Villalta, Satoshi Ishii, Emily P. Balskus, Silvia Balbo, Alexander Khoruts · 2024 · Gut Microbes
  45. Elucidating the genotoxicity of Fusobacterium nucleatum-secreted mutagens in colorectal cancer carcinogenesis
    Wenye Xu, Yuchen Zhang, Dong-jiao Chen, Dan Huang, Yang Zhao, Wei Hu, Ling Lin, Yingzhi Liu, Shilan Wang, Judeng Zeng et al. · 2024 · Gut Pathogens
  46. Colibactin-induced damage in bacteria is cell contact independent
    Emily Lowry, Amir Mitchell · 2024 · mBio
  47. The role of the urinary microbiome in genitourinary cancers
    Seoho Lee, Karen Sandell Sfanos, Nirmish Singla · 2025 · Nature Reviews Urology
  48. Cancer trigger or remedy: two faces of the human microbiome
    Anna Grenda, Paweł Adam Krawczyk · 2021 · Applied Microbiology and Biotechnology
  49. A bacterial mutational footprint in colorectal cancer genomes
    Axel Rosendahl Huber, Cayetano Pleguezuelos‐Manzano, Jens Puschhof · 2021 · British Journal of Cancer
  50. The Microbiome Colorectal Cancer Puzzle: Initiator, Propagator, and Avenue for Treatment and Research
    Reece J. Knippel, Cynthia L. Sears · 2021 · Journal of the National Comprehensive Cancer Network
  51. OUP accepted manuscript
    Noah P. Bradley, Lauren A. Washburn, Plamen P. Christov, Coran M. H. Watanabe, Brandt F. Eichman · 2020 · Nucleic Acids Research
  52. Structural Basis for the Interactions of the Colibactin Resistance Gene Product ClbS with DNA
    Prabhanshu Tripathi, Steven D. Bruner · 2021 · Biochemistry
  53. Intratumoral microbiome: the double-edged sword in remodeling cancer immunotherapy
    Di Yan, Ying Yu, Chengtong Liang, Zixing Cui, Lei Shi, Guiling Li, Chuanli Ren · 2026 · Molecular Cancer
  54. The Role of Cyclomodulins and Some Microbial Metabolites in Bacterial Microecology and Macroorganism Carcinogenesis
    Natalia N. Markelova, Elena Fedorovna Semenova, Синева Ольга Николаевна, Vera S. Sadykova · 2022 · International Journal of Molecular Sciences
  55. Structural basis of the amidase ClbL central to the biosynthesis of the genotoxin colibactin
    Prabhanshu Tripathi, Jarrod J. Mousa, Naga Sandhya Guntaka, Steven D. Bruner · 2023 · Acta Crystallographica Section D Structural Biology
  56. The role of intestinal flora on tumor immunotherapy: recent progress and treatment implications
    Yimin Zhou, Xiangdong Liu, Wei Gao, Xin Luo, Junying Lv, Yunshan Wang, Duanrui Liu · 2023 · Heliyon
  57. Intratumoral microorganisms in tumors of the digestive system
    Mengjuan Xuan, Xinyu Gu, Yingru Liu, Yang Li, Yi Li, Di Huang, Juan Li, Chen Xue · 2024 · Cell Communication and Signaling
  58. Intratumoral microbiota as a novel prognostic indicator in bladder cancer
    Yuwei Zhang, Hao Lin, Linghui Liang, Shengkai Jin, Jing Guo Lv, Yu-hua Zhou, Feng Xu, Fengping Liu, Ninghan Feng · 2024 · Scientific Reports
  59. The gut-tumor connection: the role of microbiota in cancer progression and treatment strategies
    Ziqing Wei, Guangqi Gao, Qiuwen He, Lai‐Yu Kwok, Zhihong Sun · 2025 · Journal of Advanced Research
  60. The Fanconi anemia pathway repairs colibactin-induced DNA interstrand cross-links
    Maria Altshuller, He Xu, Elliot J. MacKrell, Kevin M. Wernke, Yougant Airan, Joel W. H. Wong, Selene Sellés‐Baiget, Ting‐Yu Wang, Tsui‐Fen Chou, Julien P. Duxin et al. · 2025 · Nature Communications
  61. Intratumoral Microbiota: Unraveling their Oncogenic Impact on Cancer Progression With Focus on Breast Cancer Therapeutic Outcomes
    Chun‐Ming Chang, Ho Yin Pekkle Lam · 2024 · Anticancer Research
  62. Mutagenicity of Helicobacter hepaticus infection in the lower bowel mucosa of 129/SvEv Rag2−/‐Il10−/−gpt delta mice is influenced by sex
    Zhongming Ge, Yan Feng, Alexander Sheh, Sureshkumar Muthupalani, Guanyu Gong, Supawadee Chawanthayatham, John M. Essigmann, James G. Fox · 2019 · International Journal of Cancer
  63. Bacteria–Cancer Interface: Awaiting the Perfect Storm
    Jonathan Pommer Hansen, Waled Mohammed Ali, Rajeeve Sivadasan, Karthika Rajeeve · 2021 · Pathogens
  64. Microbial metabolites damage DNA
    Jens Puschhof, Cynthia L. Sears · 2022 · Science
  65. Escherichia coli
    Dina Jnani, Sidhartha D. Ray · 2023 · Elsevier eBooks
  66. Gut microbiota interplay with autophagy-EMT dynamics in colorectal cancer
    Tiziana Vescovo, Giulio Bontempi, Mohammadreza Bayat, Lucia Piredda, Marco Fidaleo, Raffaele Strippoli, Manuela Antonioli · 2025 · Frontiers in Cell and Developmental Biology
  67. Prevalence of genotoxic bacteria in men undergoing biopsy for prostate cancer
    John H. Lee, Brian L. Wickes, Jianmin Fu, Nohelli E. Brockman, Harshit Garg, Christian Jobin, Teresa L. Johnson‐Pais, Robin J. Leach, Zhao Lai, Michael Andre Liss · 2023 · The Prostate
  68. Global research on the crosstalk between intestinal microbiome and colorectal cancer: A visualization analysis
    Shanshan Yang, Shaodong Hao, Hui Ye, Xuezhi Zhang · 2023 · Frontiers in Cellular and Infection Microbiology
  69. Gut bacteria, host immunity, and colorectal cancer: From pathogenesis to therapy
    Yuyi Li, Jinjin Peng, Xiangjun Meng · 2024 · European Journal of Immunology
  70. Comprehensive retrospect and future perspective on bacteriophage and cancer
    Zhong Liping, Yu Sheng, Yinhang Wu, Song Yifei, Huang Jiaqun, Yu Xiaojian, Shuwen Han, Zhuang Jing · 2024 · Virology Journal
  71. Colorectal Organoids: Models, Imaging, Omics, Therapy, Immunology, and Ethics
    Martina Taglieri, Linda Di Gregorio, Serena Matis, Chiara Rosa Maria Uras, Massimo Ardy, Sara Casati, Monica Marchese, Alessandro Delli Poggi, Lizzia Raffaghello, Roberto Benelli · 2025 · Cells
  72. PreTA-mediated metabolism of 5-fluorouracil by intratumoral Citrobacter freundii drives chemoresistance in pancreatic cancer
    Weiben Xu, Ying Zhou, Haiying Ding, Mengqian Ye, Shujing Li, Linwei Xu, Xiangyu Jin, Zha‐Jun Zhan, Lulu Song, Yuhua Zhang et al. · 2025 · Cell Reports
  73. Considerations for the Use of Mutation as a Regulatory Endpoint in Risk Assessment
    Joanna Klapacz, B. Bhaskar Gollapudi · 2019 · Environmental and Molecular Mutagenesis
  74. The Regional Specificity of Mucosa-Associated Microbiota in Patients with Distal Colorectal Cancer
    Yoshihiko Kono, Ryo Inoüe, Takumi Teratani, Mineyuki Tojo, Yuko Kumagai, So Morishima, Koji Koinuma, Alan Kawarai Lefor, Joji Kitayama, Naohiro Sata et al. · 2021 · Digestion
  75. Structural evolution of a DNA repair self-resistance mechanism targeting genotoxic secondary metabolites
    E.A. Mullins, Jonathan Dorival, Gong‐Li Tang, Dale L. Boger, Brandt F. Eichman · 2021 · Nature Communications
  76. Architecture of a PKS-NRPS hybrid megaenzyme involved in the biosynthesis of the genotoxin colibactin
    Sarah Bonhomme, Carlos Contreras‐Martel, Andréa Dessen, Pauline Machebœuf · 2023 · Structure
  77. Interaction profiling methods to map protein and pathway targets of bioactive ligands
    Jun Huang, John S. Coukos, Raymond E. Moellering · 2020 · Current Opinion in Chemical Biology
  78. Stool pattern is associated with not only the prevalence of tumorigenic bacteria isolated from fecal matter but also plasma and fecal fatty acids in healthy Japanese adults
    Daiki Watanabe, Haruka Murakami, Harumi Ohno, Kumpei Tanisawa, Kana Konishi, Kikue Todoroki-Mori, Yuta Tsunematsu, Michio Sato, Yuji Ogata, Noriyuki Miyoshi et al. · 2021 · BMC Microbiology
  79. Characterization of Escherichia coli harboring colibactin genes (clb) isolated from beef production and processing systems
    Manita Guragain, John William Schmidt, Norasak Kalchayanand, Aaron M. Dickey, Joseph M. Bosilevac · 2022 · Scientific Reports
  80. Effect of gut microbiota on colorectal cancer progression and treatment
    Glowi A. Alasiri · 2022 · Saudi Medical Journal
  81. Rare UV-resistant cells in clonal populations of Escherichia coli
    Shunsuke Ichikawa, Mika Okazaki, Mina Okamura, Norihiro Nishimura, Hideto Miyake · 2022 · Journal of Photochemistry and Photobiology B Biology
  82. Multi-omics insights into the interplay between gut microbiota and colorectal cancer in the “microworld” age
    An-Jun Wang, Dingka Song, Yue-Mei Hong, Ningning Liu · 2023 · Molecular Omics
  83. Tumor-associated microbiota in colorectal cancer with vascular tumor thrombus and neural invasion and association with clinical prognosis
    Mingjie Li, Min Jin, Lei Zhao, Dandan Yu, Yan Li, Linli Shi, Bin Zhou, Li Liu, Yinghao Cao, Kailin Cai et al. · 2023 · Acta Biochimica et Biophysica Sinica
  84. Changes in the gut microbiome of patients with esophageal cancer: A systematic review and meta-analysis based on 16S gene sequencing technology
    Jieyin Deng, Ye Huang, Ke Yu, Hong Luo, Daijun Zhou, Dong Li · 2024 · Microbial Pathogenesis
  85. The Role of Microbiota in Upper Gastrointestinal Cancers
    Giovanni Marasco, Luigi Colecchia, Daniele Salvi, Angelo Bruni, Cecilia Capelli, Elton Dajti, Maria Raffaella Barbaro, Cesare Cremon, Vincenzo Stanghellini, Giovanni Barbara · 2025 · Cancers
  86. A host-centric view of the microbiota metabolome
    Takahiro Yamada, Noah W. Palm · 2025 · Immunity
  87. Biodiversity and biogeography of the multi-kingdom cancer microbiome
    Anders B. Dohlman, Robin Mjelle, Henry M. Wood, Kevin Jiang, Alaina Shumate, Iris Lee, Gianmarco Piccinno, Garazi Serna, Abdul-Rakeem Yakubu, Paolo Giovanni Nuciforo et al. · 2026 · Cell
  88. Mass spectrometry-based DNA adductomics
    Yuxiang Cui, Yinsheng Wang · 2022 · TrAC Trends in Analytical Chemistry
  89. Biosynthesis of DNA-Alkylating Antitumor Natural Products
    Qiuyue Nie, Yu Hu, Xianfeng Hou, Gong‐Li Tang · 2022 · Molecules
  90. Commonalities and differences in the mutational signature and somatic driver mutation landscape across solid and hollow viscus organs
    Aik Seng Ng, Dedrick Kok Hong Chan · 2023 · Oncogene
  91. DNA damage in colon mucosa of Pirc rats, an Apc-driven model of colon tumorigenesis
    Katia Tortora, Francesco Vitali, Carlotta De Filippo, Giovanna Caderni, Lisa Giovannelli · 2020 · Toxicology Letters
  92. Colibactin DNA damage signature indicates causative role in colorectal cancer
    Paulina J. Dziubańska-Kusibab, Hilmar Berger, Federica Battistini, Britta A. M. Bouwman, Amina Iftekhar, Riku Katainen, Nicola Crosetto, Modesto Orozco, Lauri A. Aaltonen, Thomas F. Meyer · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  93. DNA Adductomics: A Narrative Review of Its Development, Applications, and Future
    Mengqiu Cao, Xinyu Zhang · 2024 · Biomolecules
  94. Epigenetics and gut microbiome of reptiles can reveal potential targets to improve human health and performance
    Ruqaiyyah Siddiqui, Adeelah Alvi, Saif S. Alqassim, Ahmad M. Alharbi, Ayman Saeed Alhazmi, Naveed Ahmed Khan · 2025 · Discover Bacteria.
  95. Exploring preventive and treatment strategies for oral cancer: Modulation of signaling pathways and microbiota by probiotics
    Mohamed Jamal Saadh, Omer Qutaiba B. Allela, Radhwan Abdul Kareem, Gaurav V. Sanghvi, Suhas Ballal, K.Satyam Naidu, Lakshay Bareja, Mamata Chahar, Sofia Gupta, Hayder Naji Sameer et al. · 2025 · Gene
  96. Genetic heterogeneity of colorectal cancer and the microbiome
    M. A. Senchukova · 2023 · World Journal of Gastrointestinal Oncology
  97. Transformation of colitis and colorectal cancer: a tale of gut microbiota
    Kai Xia, Renyuan Gao, Lin Li, Xiaocai Wu, Tianqi Wu, Yu Ruan, Lu Yin, Chunqiu Chen · 2023 · Critical Reviews in Microbiology
  98. Activity‐Based Protein Profiling Identifies Protein Disulfide‐Isomerases as Target Proteins of the Volatile Salinilactones
    Karoline Jerye, Helko Lüken, Anika Steffen, Christian Schlawis, Lothar Jänsch, Stefan Schulz, Mark Brönstrup · 2024 · Advanced Science
  99. Crosstalk Between the Intratumoral Microbiota and the Tumor Microenvironment: New Frontiers in Solid Tumor Progression and Treatment
    Qing Zhou, Lijun Zhou, Xi Chen, Qiuyan Chen, Lu Hao · 2024 · Cancer Reports
  100. Microbiome and gastrointestinal malignancies
    Ibrahim M. Sayed, Haidi Karam‐Allah Ramadan, Mohamed A. El‐Mokhtar, Lobna Abdel-Wahid · 2021 · Current Opinion in Physiology